Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein
Inventor: Robert Sabin Read MoreDownload PatentAbstract
A composition and method for the treatment of Alzheimer’s disease and related amyloid plaque development and reduction of amyloid plaque, amyloidosis and amyotrophic lateral sclerosis, includes an effective amount of a compound selected from the group consisting of phytic acid, a phytate salt, an isomer or hydrolysate of phytic acid or a phytate salt, or a mixture of any combination thereof, being administered to a person in an amount from about 0.5 grams to about 18.75 grams per day.
Patent Number
US11510932B2
United States
2020-10-06
Application filed by Individual
2020-10-06
Priority to US17/064,536
2021-02-11
Publication of US20210038618A1
2022-10-26
Priority to US17/974,055
2022-11-29
Application granted
2022-11-29
Publication of US11510932B2
Status • Active
2030-08-14
Adjusted expiration
Keywords:
Alpha-secretase; Alzheimer’s disease; amyloid hypothesis; amyloid plaque; amyloid precursor protein; amyloid-alpha peptide; amyloid-beta peptide; apolipoprotein E; beta-secretase; inherited Alzheimer’s disease; non-inherited Alzheimer’s disease.